<DOC>
	<DOCNO>NCT00087360</DOCNO>
	<brief_summary>RATIONALE : Evaluating knowledge attitude healthy participant toward new diet gene test colorectal cancer risk may help doctor improve acceptance colorectal cancer screening . PURPOSE : This clinical trial study knowledge attitude healthy participant toward genetic environmental risk assessment colorectal cancer .</brief_summary>
	<brief_title>Genetic Environmental Risk Assessment Colorectal Cancer Healthy Participants</brief_title>
	<detailed_description>OBJECTIVES : Part 1 - Determine willingness healthy participant enroll genetic environmental risk assessment colorectal cancer . - Determine impact decision counsel knowledge attitude genetic environmental risk assessment ( GERA ) colorectal cancer screen participant . - Determine participant ' understand GERA . - Determine participant ' response GERA result . Part 2 - Determine awareness , interest , diet genetic assessment colorectal cancer among healthy participant average risk colorectal cancer undergone regular colon cancer screen . - Determine participant ' level knowledge assessment . - Determine participant ' rate acceptance study . OUTLINE : This 2-part pilot study . - Part 1 : Participants complete baseline questionnaire attitude , belief , knowledge colorectal cancer ( CRC ) , CRC screening , diet genetic test colorectal cancer risk . Two-four week later , participant educate CRC screen option undergo genetic environmental risk assessment ( GERA ) decision counsel methylene tetrahydrofolate reductase ( MTHFR ) gene dietary folate intake . Participants decide undergo GERA undergo blood test MTHFR polymorphisms folate level . Participants whose blood test indicate low folate level counsel dietary folate intake . - Part 2 : Participants complete questionnaire attitude , belief , knowledge CRC , CRC screening , diet genetic test colorectal cancer risk . Participants part 1 follow 1 week , 1 month , 6 month . PROJECTED ACCRUAL : A total 110 participant ( 60 part 1 50 part 2 ) accrue study .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Healthy participant Eligible colorectal cancer screen No personal family history colorectal cancer No 1 firstdegree relative colorectal cancer Part 1 : Has undergone regular screening colorectal cancer Part 2 : Not currently undergo regular colon cancer testing , include follow : Fecal occult blood test within past year Flexible sigmoidoscopy colonoscopy within past 5 year PATIENT CHARACTERISTICS : Age 50 74 Performance status Not specify Life expectancy Not specify Hematopoietic Not specify Hepatic Not specify Renal Not specify Other No inflammatory bowel disease ( part 1 ) No concurrent health issue would preclude study participation ( part 1 ) No history cancer except basal cell squamous cell skin cancer ( part 2 ) Able speak read English ( part 2 ) PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Not specify Endocrine therapy Not specify Radiotherapy Not specify Surgery Not specify</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>colon cancer</keyword>
	<keyword>rectal cancer</keyword>
</DOC>